Concomitant Implantation of Impella® on Top of Veno-Arterial Extracorporeal Membrane Oxygenation May Improve Survival of Patients with Cardiogenic Shock

Key Points

Key points are not available for this paper at this time.

Abstract

Concomitant treatment with VA-ECMO and Impella may improve outcome in patients with cardiogenic shock compared with VA-ECMO only. Nevertheless, randomized studies are needed to validate these promising results further.

Read Full Paperexternally

Bookmark

View Full Paper

Bookmark

View Full Paper

Cite This Study

Pappalardo et al. (Thu,) studied this question.

synapsesocial.com/papers/69e5dc947051b84d08e7068c https://doi.org/https://doi.org/10.1002/ejhf.668